Viropro Inc.
VPRO · OTC
9/30/2011 | 6/30/2011 | 3/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.27 | -0.07 | 0.00 | 0.00 |
| FCF Yield | 0.81% | -2.70% | -2.34% | 0.00% |
| EV / EBITDA | -72.96 | -27.59 | -25.95 | -0.92 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 1,004,262.94% | 929,701.09% | 929,505.95% | 829,566.48% |
| Free Cash Flow Growth | 166.34% | -185.87% | -314.43% | 159.66% |
| Safety | ||||
| Net Debt / EBITDA | -15.34 | 0.07 | -0.22 | -0.92 |
| Interest Coverage | 0.00 | -494.49 | -216.49 | -109.44 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 19.33 | 21.45 | 34.60 | 53.80 |